|
PSMG4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.870100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.810100E-02 |
| Normal-vs-Stage2 |
8.751800E-01 |
| Normal-vs-Stage3 |
5.381800E-01 |
| Normal-vs-Stage4 |
1.999160E-01 |
| Stage1-vs-Stage2 |
2.178600E-01 |
| Stage1-vs-Stage3 |
8.620200E-01 |
| Stage1-vs-Stage4 |
4.121800E-01 |
| Stage2-vs-Stage3 |
5.566400E-01 |
| Stage2-vs-Stage4 |
1.573790E-01 |
| Stage3-vs-Stage4 |
4.151200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.138100E-02 |
| Normal-vs-AfricanAmerican |
5.563200E-01 |
| Normal-vs-Asian |
2.817000E-01 |
| Caucasian-vs-AfricanAmerican |
3.039800E-01 |
| Caucasian-vs-Asian |
9.077000E-01 |
| AfricanAmerican-vs-Asian |
6.581800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.207040E-01 |
| Normal-vs-Female |
1.439400E-01 |
| Male-vs-Female |
6.819400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.425000E-01 |
| Normal-vs-Extreme_Weight |
5.896100E-02 |
| Normal-vs-Obese |
2.893400E-01 |
| Normal-vs-Extreme_Obese |
1.958560E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.289800E-01 |
| Normal_Weight-vs-Obese |
6.411600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.402600E-01 |
| Extreme_Weight-vs-Obese |
5.128000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.700800E-01 |
| Obese-vs-Extreme_Obese |
2.174400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.393600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.001960E-01 |
| Normal-vs-Age(61-80Yrs) |
1.116800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.446200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.402200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.732200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.293600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.835800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.155420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.732300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.208210E-02 |
| Normal-VS-Type2 PRCC |
6.286000E-01 |
| Normal-VS-KIRP CIMP |
2.009600E-01 |
| Normal-VS-Unclassified PRCC |
9.124400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.620680E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.816000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.500200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.717240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.845800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.980580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.786200E-01 |
| Normal-vs-N1 |
2.729000E-01 |
| Normal-vs-N2 |
2.150400E-01 |
| N0-vs-N1 |
6.286400E-01 |
| N0-vs-N2 |
2.363400E-01 |
| N1-vs-N2 |
3.153600E-01 |
|
|
